about
Achalasia: a review of clinical diagnosis, epidemiology, treatment and outcomesDietary fiber intake and risk of colorectal cancer and incident and recurrent adenoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis.Aspects of dietary carbohydrate intake are not related to risk of colorectal polyps in the Tennessee Colorectal Polyp Study.Colorectal Cancer Risk Following Adenoma Removal: A Large Prospective Population-Based Cohort Study.Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trialSymptoms and endoscopic features at barrett's esophagus diagnosis: implications for neoplastic progression risk.Population-based study reveals new risk-stratification biomarker panel for Barrett's esophagus.Whole slide image cytometry: a novel method to detect abnormal DNA content in Barrett's esophagus.Increasing incidence of Barrett's oesophagus: a population-based study.Digital slide viewing for primary reporting in gastrointestinal pathology: a validation study.Heller's myotomy and pneumatic dilatation in the treatment of achalasia: a population-based case-control study assessing long-term quality of life.Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study.Lifestyle factors and small intestine adenocarcinoma risk: A systematic review and meta-analysis.Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort.Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink.Characterization of the timing and prevalence of receptor tyrosine kinase expression changes in oesophageal carcinogenesis.Dietary carbohydrate intake, glycemic index, and glycemic load and endometrial cancer risk: a prospective cohort study.Beta-blocker usage and prostate cancer survival: A nested case–control study in the UK Clinical Practice Research Datalink cohortBeta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study
P50
Q26992109-8DE1EA32-E3AD-4000-A2F7-E8562FFE19C1Q34044636-0BD39BF2-A46D-410D-A962-F5F794697375Q34354632-56C7DBB6-6E65-4E0A-B79E-BC3FF88A7C2DQ35842052-B2B0B533-2BB8-436C-BE7C-A2519D553179Q36029617-1D03FC5B-7956-47D4-87D9-F031F2624CEFQ36951740-825A7CE0-9CBD-4BC9-BB0B-08BD1F60B9DCQ38192838-ADF34C56-2E76-45D9-9005-5E9CA1259E05Q38323804-E3E8D5B3-2D66-433B-8B69-78B5327C4FD2Q38559655-5F43D458-4161-41B5-BACA-3A5D553B4DE7Q39739602-B8DFA18D-8412-465A-8EE8-E68ECC1D6574Q40281167-6F07EE0C-35CB-4501-9300-7D36C1677E36Q41146801-4E6888AE-AEF1-4EAF-B5A3-A8E3F7E6DB01Q48874889-94FE708F-C6E0-4CE0-81F7-B8012CFE40A0Q50450663-5F816E91-3669-47B6-88B3-52850E08AD56Q51160029-C83F593E-C3C0-490B-B8B4-A5DDF2228A40Q54484100-15DE0463-5CF7-499C-BEC0-55C9EC719BC1Q54501808-095F7BCC-ABFB-4EE8-A5CA-D80283ADBD3BQ54966331-EF67764F-3B61-4C31-9083-62AFE90334AEQ55969166-8207C951-293B-4EFD-BF22-993D128B59D7Q58966970-B01087D9-392C-4236-86DB-54ADD73BDC3F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Helen G Coleman
@ast
Helen G Coleman
@en
Helen G Coleman
@es
Helen G Coleman
@nl
type
label
Helen G Coleman
@ast
Helen G Coleman
@en
Helen G Coleman
@es
Helen G Coleman
@nl
prefLabel
Helen G Coleman
@ast
Helen G Coleman
@en
Helen G Coleman
@es
Helen G Coleman
@nl
P106
P31
P496
0000-0003-4872-7877